Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vabysmo in diabetic macular edema with limited response to aflibercept
NCT05610488Phase 4Unknown
- Sponsor
- Vista Klinik
- Start
- Nov 2022
- Primary completion
- Dec 2023
- Modality
- Bispecific Antibodies, Monoclonal Antibodies
01
Overview
A Phase 4 trial of faricimab in diabetic macular edema (DME), sponsored by Vista Klinik. Status: unknown.
02
Drugs
faricimab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT05610488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05610488.